Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective
Abstract Background Traditional clinical trials require tests and procedures that are administered in centralized clinical research sites, which are beyond the standard of care that patients receive for their rare and chronic diseases. The limited number of rare disease patients scattered around the...
| Үндсэн зохиолчид: | , , , , , , , , , |
|---|---|
| Формат: | Өгүүллэг |
| Хэл сонгох: | English |
| Хэвлэсэн: |
BMC
2023-04-01
|
| Цуврал: | Orphanet Journal of Rare Diseases |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1186/s13023-023-02693-7 |